-
covariants
Real-time updates and information about key SARS-CoV-2 variants, plus the scripts that generate this information.
-
InfluxDB
Power Real-Time Data Analytics at Scale. Get real-time insights from all types of time series data with InfluxDB. Ingest, query, and analyze billions of data points in real-time with unbounded cardinality.
So it's not really hoping for the best. It's using the best tools we have to reach herd immunity, both natural and artificial. The problem when we mass vaccinate, with mRNA vaccines that focus on a spike, is that variants that can circonvolute the immunity put in place by the vaccine, have it a lot easier than before to take over. You can see this in the data on covariants.org very clearly. This renders the vaccine a lot less effective as those variants have no natural competition. Thus putting the people that really need the vaccine, the people at risk, in a lot more danger, even vaccinated. This is why a lot of experts advised since the start to not mass vaccinate like we did. Sadly they weren't heard.
Related posts
-
At what point do you think things will change?
-
China's Covid cases hit record as dissent grows over tough restrictions
-
COVID in California: Newer variants cause more symptoms, study says
-
Scientists Fear New COVID Strains Are Deadly—Just Like 2020 Wave
-
Some people are saying the 2nd or 3rd time you get COVID the symptoms are much milder. Some are saying the symptoms their symptoms were not as bad their first time having it. For those who’ve had it more than once, how was your experience?